Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Yissum

CTech 24/7

  • Intel Products CEO: “Employees are very optimistic about the fact that Lip-Bu can help us”
  • For digital bank One Zero, AI is “a central growth engine”
  • Amdocs on AI: “We simply cannot adopt every new solution that emerges”
  • Intel CEO backs $44M round for Speedata as Israeli chipmaker targets big data bottlenecks
More stories in CTech

Yissum

4 stories about Yissum
  • Itzik Goldwaser Yissum

    Israel’s tech ecosystem needs to address the start-up “Valley of Death”

    20.03.22|Itzik Goldwaser"The Israeli tech ecosystem may be in the spotlight with dozens of new unicorns in just a few years, combined with a flurry of SPACs, yet the uncomfortable fact is that 2021 yielded a record low number of new startups," writes Itzik Goldwaser, CEO of Yissum

  • New York. Photo: Shutterstock

    Yeshiva University Launches Joint New York Innovation Lab, With Hebrew University as Strategic Partner

    21.05.19|Meir OrbachThe lab, located on Yeshiva University’s campus, will help Israeli startups looking to expand to the U.S. market make connections within New York’s tech and business environment

  • The Hebrew University of Jerusalem. Photo: David Rubinger

    Hebrew University Tech Transfer Arm Yissum Launches Nano Technology Fund

    09.10.18|Meir Orbach The new fund will focus on innovations in the fields of smart materials, 3D printing, quantum science, and renewable energy

  • A colony of haploid human embryonic stem cells. Photo: PR

    NewStem, Which Screens Patients for Resistance to Chemotherapy, Raises $2 Million

    16.07.18|Asaf ShalevThe Jerusalem-based startup is creating a proprietary database of mutated genes that cause resistance to different types of chemotherapeutic agents

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive